tm logo
PROGRESS MADE POSSIBLE
Live/Pending
FIRST EXTENSION - GRANTED

granted

on 17 Apr 2024

Last Applicant/ Owned by

3515 Lyman Blvd.

Chaska

MN

55318

Serial Number

97600111 filed on 21st Sep 2022

Registration Number

N/A

Correspondent Address

Jodi A. DeSchane BALLARD SPAHR LLP

2000 IDS CENTER, 80 SOUTH 8TH STREET

MINNEAPOLIS, MN 55402

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

PROGRESS MADE POSSIBLE

designing and developing pharmaceuticals; inspection of custom designed and manufactured pharmaceuticals regulatory compliance consulting in the field of pharmaceuticals and medical devices hyaluronic acid and the sodium salt therefrom, namely, sodium hyaluronate, sold as a raw chemical for use in manufacturing processes, namely, for use in compounding pharmaceuticals or cosmetics regulatory suRead More

Classification Information


Class [045]
Personal & Legal & Social Services


regulatory compliance consulting in the field of pharmaceuticals and medical devices


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [042]
Computer & Software Services & Scientific Services


designing and developing pharmaceuticals; inspection of custom designed and manufactured pharmaceuticals


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [039]
Transportation & Storage Services


packaging of custom designed and manufactured pharmaceuticals for others, namely, filling syringes, vials and bags, labeling, pouching, and traying


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [035]
Advertising, Business & Retail Services


regulatory submission management, namely, assisting others in preparing documents and information for their filing of applications for new drugs and medical devices with governmental regulatory bodies


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [005]
Pharmaceutical Products


pharmaceutical preparations containing hyaluronic acid, sodium hyaluronate, or a derivative of hyaluronic acid for use in eye surgery, repair of flexible tissue, and injectable drug delivery compounds used as a facilitating agent for other pharmaceuticals


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [001]
Chemical Products


hyaluronic acid and the sodium salt therefrom, namely, sodium hyaluronate, sold as a raw chemical for use in manufacturing processes, namely, for use in compounding pharmaceuticals or cosmetics


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Class [040]
Treatment & Processing of Materials Services


contract manufacturing in the field of fermentation services for microbial and yeast fermentation; custom formulation of pharmaceuticals


First Use Date in General

11th 000101

First Use Date in Commerce

11th 000101

Mark Details


Serial Number

No 97600111

Mark Type

No Service Mark

Attorney Docket Number

No 00389132

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
07th May 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
18th Apr 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17th Apr 2024SOU EXTENSION 1 GRANTED
17th Apr 2024SOU EXTENSION 1 FILED
17th Apr 2024SOU TEAS EXTENSION RECEIVED
17th Apr 2024TEAS STATEMENT OF USE RECEIVED
17th Oct 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
22nd Aug 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22nd Aug 2023PUBLISHED FOR OPPOSITION
02th Aug 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED